Blood Res  
What is the most appropriate regimen for untreated Waldenströmmacroglobulinemia? - Anupdated analysis of rituximab and half-dose CHOP therapy and cost effectiveness
Naohiro Sekiguchi1, 2, Airi Hamano3,Tomoko Kitagawa2, Kenichi Ito1,Kazuhiko Hirano4, Kazuaki Yamada4
1Hematology Division, 2Clinical Research Division, 3PharmaceuticalDivision, 4Laboratory and Pathology Division, National Hospital Organization Disaster Medical Center, Tokyo, Japan
Correspondence to: NaohiroSekiguchi
Hematology Division, National Hospital Organization Disaster Medical Center, 3256 Midori-cho, Tachikawa, Tokyo 190-0014, Japan
Published online: March 27, 2019.
© The Korean Journal of Hematology. All rights reserved.

cc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.


This Article

Current Issue


Indexed/Covered by

Today : 12  /
Total : 135,617